These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38484070)

  • 1. 'Damning' FDA inspection report undermines Alzheimer's drug.
    Piller C
    Science; 2024 Mar; 383(6688):1165-1166. PubMed ID: 38484070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probe of Alzheimer's studies finds 'egregious misconduct'.
    Piller C
    Science; 2023 Oct; 382(6668):251-252. PubMed ID: 37856608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research backing experimental Alzheimer's drug was first target of suspicion.
    Piller C
    Science; 2022 Jul; 377(6604):363. PubMed ID: 35862516
    [No Abstract]   [Full Text] [Related]  

  • 4. Research backing experimental Alzheimer's drug was first target of suspicion.
    Piller C
    Science; 2022 Jul; 377(6604):363. PubMed ID: 35862534
    [No Abstract]   [Full Text] [Related]  

  • 5. Research misconduct identified by the US Food and Drug Administration: out of sight, out of mind, out of the peer-reviewed literature.
    Seife C
    JAMA Intern Med; 2015 Apr; 175(4):567-77. PubMed ID: 25664866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA queries Alzheimer's trial results.
    Marx JL
    Science; 1988 Feb; 239(4843):969. PubMed ID: 3278380
    [No Abstract]   [Full Text] [Related]  

  • 7. Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    Kurkinen M; Tran L
    J Alzheimers Dis; 2021; 84(3):969-971. PubMed ID: 34657888
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrine as a treatment for Alzheimer's dementia: editor's note. An interim report from the FDA. A response from Summers et al.
    N Engl J Med; 1991 Jan; 324(5):349-52. PubMed ID: 1986300
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA sanctions for misconduct in clinical trials; results published as if nothing were amiss.
    Prescrire Int; 2015 Dec; 24(166):307. PubMed ID: 26788584
    [No Abstract]   [Full Text] [Related]  

  • 10. Raising suspicions with the Food and Drug Administration: detecting misconduct.
    Hamrell MR
    Sci Eng Ethics; 2010 Dec; 16(4):697-704. PubMed ID: 20842536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Access to FDA Inspection Reports on Irregularities and Misconduct in Clinical Trials.
    Dal-Ré R; Kesselheim AS; Bourgeois FT
    JAMA; 2020 May; 323(19):1903-1904. PubMed ID: 32324205
    [No Abstract]   [Full Text] [Related]  

  • 12. The future is now: model-based clinical trial design for Alzheimer's disease.
    Romero K; Ito K; Rogers JA; Polhamus D; Qiu R; Stephenson D; Mohs R; Lalonde R; Sinha V; Wang Y; Brown D; Isaac M; Vamvakas S; Hemmings R; Pani L; Bain LJ; Corrigan B; ;
    Clin Pharmacol Ther; 2015 Mar; 97(3):210-4. PubMed ID: 25669145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA steps up efforts to find, remove violators of clinical trial regulations.
    Kuehn BM
    JAMA; 2009 Oct; 302(16):1739-41. PubMed ID: 19861661
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves galantamine for Alzheimer's disease.
    Thompson CA
    Am J Health Syst Pharm; 2001 Apr; 58(8):649. PubMed ID: 11329755
    [No Abstract]   [Full Text] [Related]  

  • 15. Rethinking the Food and Drug Administration's 2013 guidance on developing drugs for early-stage Alzheimer's disease.
    Schneider LS
    Alzheimers Dement; 2014 Mar; 10(2):247-50. PubMed ID: 24698029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on trial death stokes Alzheimer's drug fears.
    Piller C
    Science; 2023 Apr; 380(6641):122-123. PubMed ID: 37053319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversial Approval of New Drug to Treat Alzheimer's Disease.
    Aschenbrenner DS
    Am J Nurs; 2021 Oct; 121(10):22-23. PubMed ID: 34554982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug shows promise for treatment of Alzheimer's disease.
    Frankish H
    Lancet Neurol; 2006 Apr; 5(4):300. PubMed ID: 16578921
    [No Abstract]   [Full Text] [Related]  

  • 19. The Search for a Drug to End Alzheimer's.
    Campbell S
    IEEE Pulse; 2021; 12(2):2-7. PubMed ID: 33861693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical drug trials in Alzheimer disease. What are some of the issues?
    Jarvik LF; Berg L; Bartus R; Heston L; Leith N; Phelps C; Shader R; Whitehouse P
    Alzheimer Dis Assoc Disord; 1990; 4(4):193-202. PubMed ID: 2264978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.